{"DataElement":{"publicId":"2182158","version":"3","preferredName":"Treatment Modified Quantity Treatment Modified Dose Reason","preferredDefinition":"the reason for a reduction or modification in a treatment dose.","longName":"TX_MOD_DOSE_RSN","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2442696","version":"1","preferredName":"Treatment Modified Quantity","preferredDefinition":"information relating to a modified treatment quantity.","longName":"TX_MODIFIED_QUAN","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2416951","version":"1","preferredName":"Therapy","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C15368","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapy","conceptCode":"C15368","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"02DBEE3F-243E-103A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-12","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-10-12","modifiedBy":"ONEDATA","dateModified":"2005-10-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2453124","version":"1","preferredName":"Modified Quantity","preferredDefinition":"Modified; changed in form or character.:Quantity; how much there is of something that you can measure.","longName":"C25573:C25256","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Modified","conceptCode":"C25573","definition":"Modified; changed in form or character.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Quantity","conceptCode":"C25256","definition":"How much there is of something that you can measure; the total amount or number.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D51E8D8-6E78-387C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-27","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-02-27","modifiedBy":"ONEDATA","dateModified":"2006-02-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008560","version":"1","preferredName":"Therapy Doses","preferredDefinition":"quantities of therapy or treatment.","longName":"TX_DOSES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30C55B6-50B5-1219-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09046428-52E8-6C1D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-01-09","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-01-09","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2182157","version":"3","preferredName":"Treatment Modified Dose Reason","preferredDefinition":"the reason for a reduction or modification in a treatment dose.","longName":"TX_MOD_DOSE_RSN","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"65","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other Complicating Disease","valueDescription":"Other Complicating Disease","ValueMeaning":{"publicId":"7765253","version":"1","preferredName":"Other Complicating Disease","longName":"7765253","preferredDefinition":"Other Complicating Disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C975B0E3-8864-2758-E053-4EBD850AD480","latestVersionIndicator":"Yes","beginDate":"2021-08-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-887D-2758-E053-4EBD850AD480","beginDate":"2021-08-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"Therapy complete","valueDescription":"Therapy Complete","ValueMeaning":{"publicId":"2979252","version":"1","preferredName":"Therapy Complete","longName":"2979252","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.: To possess every necessary or normal part or component or step; having come or been brought to a conclusion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapy","conceptCode":"C15368","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Complete","conceptCode":"C25250","definition":"To possess every necessary or normal part or component or step; having come or been brought to a conclusion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C8053AF-FFA7-03CC-E040-BB89AD4303D8","latestVersionIndicator":"Yes","beginDate":"2010-01-06","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-01-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-8785-2758-E053-4EBD850AD480","beginDate":"2017-09-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"Weight change","valueDescription":"Weight Change","ValueMeaning":{"publicId":"2871571","version":"1","preferredName":"Weight Change","longName":"2871571","preferredDefinition":"The vertical force exerted by a mass as a result of gravity.: alteration or modification.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Weight","conceptCode":"C25208","definition":"The vertical force exerted by a mass as a result of gravity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Change","conceptCode":"C25446","definition":"The act of alteration or modification; changed or altered in form or character.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"69442CAD-A176-A995-E040-BB89AD4320DF","latestVersionIndicator":"Yes","beginDate":"2009-05-06","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-05-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-878F-2758-E053-4EBD850AD480","beginDate":"2017-09-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"Death","valueDescription":"Death","ValueMeaning":{"publicId":"2561497","version":"1","preferredName":"Death","longName":"2561497","preferredDefinition":"The absence of life or state of being dead.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dead","conceptCode":"C28554","definition":"The cessation of life.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-BD46-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-07-05","endDate":null,"createdBy":"CVALMONT","dateCreated":"2002-07-05","modifiedBy":"KUMMEROA","dateModified":"2022-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-8799-2758-E053-4EBD850AD480","beginDate":"2017-09-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"Disease progression","valueDescription":"Disease Progression","ValueMeaning":{"publicId":"2561827","version":"1","preferredName":"Disease Progression","longName":"2561827","preferredDefinition":"Cancer that continues to grow or spread.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Progression","conceptCode":"C17747","definition":"A process that manifests as the worsening of a disease over time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-BE90-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-07-10","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-10","modifiedBy":"SOKKERL","dateModified":"2023-03-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-87A3-2758-E053-4EBD850AD480","beginDate":"2017-09-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"Patient refusal/noncompliance","valueDescription":"Patient refusal/noncompliance","ValueMeaning":{"publicId":"2571811","version":"1","preferredName":"Patient refusal/noncompliance","longName":"2571811","preferredDefinition":"Patient refusal/noncompliance","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E590-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-08","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-09-08","modifiedBy":"KUMMEROA","dateModified":"2023-03-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-87AD-2758-E053-4EBD850AD480","beginDate":"2017-09-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"Adverse event","valueDescription":"Adverse Event","ValueMeaning":{"publicId":"2570073","version":"1","preferredName":"Adverse Event","longName":"2570073","preferredDefinition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adverse Event","conceptCode":"C41331","definition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DEC6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"HARTLEYG","dateModified":"2021-06-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-87B7-2758-E053-4EBD850AD480","beginDate":"2017-09-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"IM-1 delayed >14 days due to ANC < 750/uL and/or PLT < 75,000/uL after InO BK1","valueDescription":"IM-1 delayed >14 days due to ANC < 750/uL and/or PLT < 75,000/uL after InO BK1","ValueMeaning":{"publicId":"6859385","version":"1","preferredName":"IM-1 delayed >14 days due to ANC < 750/uL and/or PLT < 75,000/uL after InO BK1","longName":"6859385","preferredDefinition":"IM-1 delayed >14 days due to ANC < 750/uL and/or PLT < 75,000/uL after InO BK1","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90B5A0C1-515B-6B38-E053-F662850AB3EC","latestVersionIndicator":"Yes","beginDate":"2019-08-22","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-08-22","modifiedBy":"ONEDATA","dateModified":"2019-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-87C1-2758-E053-4EBD850AD480","beginDate":"2019-08-22","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"Delay in the start of IM1 by > 14 days ue to ANC < 750/uL and/or platelets < 75,000/uL after InO Block 1 requires dose reduction for InO Block 2","valueDescription":"Delay in the start of IM1 by > 14 days ue to ANC < 750/uL and/or platelets < 75,000/uL after InO Block 1 requires dose reduction for InO Block 2","ValueMeaning":{"publicId":"6825236","version":"1","preferredName":"Delay in the start of IM1 by > 14 days ue to ANC < 750/uL and/or platelets < 75,000/uL after InO Block 1 requires dose reduction for InO Block 2","longName":"6825236","preferredDefinition":"Delay in the start of IM1 by > 14 days ue to ANC < 750/uL and/or platelets < 75,000/uL after InO Block 1 requires dose reduction for InO Block 2","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E722958-2261-3030-E053-F662850A541C","latestVersionIndicator":"Yes","beginDate":"2019-07-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-07-24","modifiedBy":"ONEDATA","dateModified":"2019-07-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-87CB-2758-E053-4EBD850AD480","beginDate":"2019-07-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"Alternative therapy for other reason","valueDescription":"Other Reason Complementary and Alternative Medicine","ValueMeaning":{"publicId":"7715477","version":"1","preferredName":"Other Reason Complementary and Alternative Medicine","longName":"7715477","preferredDefinition":"Different than the one(s) previously specified or mentioned.: An explanation of the cause of some phenomenon or action.: Forms of treatment that are used in addition to (complementary) or instead of (alternative) standard treatments. These practices generally are not considered standard medical approaches. Standard treatments go through a long and careful research process to prove they are safe and effective, but less is known about most types of CAM. CAM may include dietary supplements, megadose vitamins, herbal preparations, special teas, acupuncture, massage therapy, magnet therapy, spiritual healing, and meditation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Reason","conceptCode":"CL052595","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_META_CUI","primaryIndicator":"No","displayOrder":"1"},{"longName":"Complementary and Alternative Medicine","conceptCode":"C15178","definition":"A group of diverse medical and health care systems, practices, and products that are not presently considered to be part of conventional medicine. Complementary medicine as being used together with conventional medicine, whereas alternative medicine is used in place of conventional medicine. The National Center for Complementary and Alternative Medicine (NCCAM) groups CAM practices into four domains, recognizing there can be some overlap: mind-body medicine; biologically based practices, manipulative and body-based practices, and energy medicine. In addition, NCCAM studies CAM whole medical systems, which cut across all domains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C59D17D2-CB84-6B1C-E053-4EBD850A6555","latestVersionIndicator":"Yes","beginDate":"2021-06-25","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-06-25","modifiedBy":"ONEDATA","dateModified":"2021-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-87D5-2758-E053-4EBD850AD480","beginDate":"2021-06-25","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"Scheduling","valueDescription":"Scheduling","ValueMeaning":{"publicId":"7715478","version":"1","preferredName":"Scheduling","longName":"7715478","preferredDefinition":"Scheduling","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C59D17D2-CBA9-6B1C-E053-4EBD850A6555","latestVersionIndicator":"Yes","beginDate":"2021-06-25","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-06-25","modifiedBy":"ONEDATA","dateModified":"2021-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-87DF-2758-E053-4EBD850AD480","beginDate":"2021-06-25","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"Patient withdrawal/refusal after beginning protocol therapy","valueDescription":"Patient withdrawal/refusal after beginning protocol therapy","ValueMeaning":{"publicId":"7765251","version":"1","preferredName":"Patient withdrawal/refusal after beginning protocol therapy","longName":"7765251","preferredDefinition":"Patient withdrawal/refusal after beginning protocol therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C975B0E3-881E-2758-E053-4EBD850AD480","latestVersionIndicator":"Yes","beginDate":"2021-08-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-8837-2758-E053-4EBD850AD480","beginDate":"2021-08-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"Patient withdrawal/refusal prior to beginning protocol therapy","valueDescription":"Patient withdrawal/refusal prior to beginning protocol therapy","ValueMeaning":{"publicId":"7765252","version":"1","preferredName":"Patient withdrawal/refusal prior to beginning protocol therapy","longName":"7765252","preferredDefinition":"Patient withdrawal/refusal prior to beginning protocol therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C975B0E3-8841-2758-E053-4EBD850AD480","latestVersionIndicator":"Yes","beginDate":"2021-08-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-885A-2758-E053-4EBD850AD480","beginDate":"2021-08-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"Dosing Error","valueDescription":"Dosing Error","ValueMeaning":{"publicId":"7765254","version":"1","preferredName":"Dosing Error","longName":"7765254","preferredDefinition":"Dosing Error","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C975B0E3-8887-2758-E053-4EBD850AD480","latestVersionIndicator":"Yes","beginDate":"2021-08-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-88A0-2758-E053-4EBD850AD480","beginDate":"2021-08-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"Death on study","valueDescription":"Death on Study","ValueMeaning":{"publicId":"2558597","version":"1","preferredName":"Death on Study","longName":"2558597","preferredDefinition":"Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research.: The cessation of life.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Study","conceptCode":"C15206","definition":"Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Dead","conceptCode":"C28554","definition":"The cessation of life.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B1F2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2016-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-866D-2758-E053-4EBD850AD480","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"Disease progression, relapse during active treatment","valueDescription":"Disease progression, relapse during active treatment","ValueMeaning":{"publicId":"2570249","version":"1","preferredName":"Disease progression, relapse during active treatment","longName":"2570249","preferredDefinition":"Disease progression, relapse during active treatment","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DF76-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-8677-2758-E053-4EBD850AD480","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"None","valueDescription":"None at all","ValueMeaning":{"publicId":"2574138","version":"1","preferredName":"None at all","longName":"2574138","preferredDefinition":"No person or thing, nobody, not any.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EEA7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"CLOHNES","dateModified":"2022-08-12","changeDescription":null,"administrativeNotes":"8/12/22 added alt VM for Alliance cjl;","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-8681-2758-E053-4EBD850AD480","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2559653","version":"1","preferredName":"Other","longName":"2559653","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B612-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-868B-2758-E053-4EBD850AD480","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"Treatment completed per protocol criteria","valueDescription":"Treatment completed per protocol criteria","ValueMeaning":{"publicId":"2570762","version":"1","preferredName":"Treatment completed per protocol criteria","longName":"2570762","preferredDefinition":"The formal plan of an experiment or research activity, including the objective, rationale, design, materials and methods for the conduct of the study; intervention description, and method of data analysis.: Indicates that the patient was fully compliant with the full course of treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Study Protocol","conceptCode":"C70817","definition":"The formal plan of an experiment or research activity, including the objective, rationale, design, materials and methods for the conduct of the study; intervention description, and method of data analysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Treatment Completed as Prescribed","conceptCode":"C105740","definition":"Indicates that the patient was fully compliant with the full course of treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E177-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"LUY","dateModified":"2015-01-30","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 01/30/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-86A9-2758-E053-4EBD850AD480","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"Adverse event/side effects/complications","valueDescription":"Adverse event/side effects/complications","ValueMeaning":{"publicId":"2563880","version":"1","preferredName":"Adverse event/side effects/complications","longName":"2563880","preferredDefinition":"Adverse event/side effects/complications","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C695-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-86BD-2758-E053-4EBD850AD480","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"No treatment, per protocol criteria","valueDescription":"No treatment, per protocol criteria","ValueMeaning":{"publicId":"2567109","version":"1","preferredName":"No treatment, per protocol criteria","longName":"2567109","preferredDefinition":"No treatment, per protocol criteria","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D332-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-10-08","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-10-08","modifiedBy":"REEVESD","dateModified":"2016-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-86C7-2758-E053-4EBD850AD480","beginDate":"2005-06-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"Alternative therapy","valueDescription":"Alternative Therapy","ValueMeaning":{"publicId":"2570086","version":"1","preferredName":"Alternative Therapy","longName":"2570086","preferredDefinition":"Forms of treatment that are used in addition to (complementary) or instead of (alternative) standard treatments. These practices generally are not considered standard medical approaches. Standard treatments go through a long and careful research process to prove they are safe and effective, but less is known about most types of CAM. CAM may include dietary supplements, megadose vitamins, herbal preparations, special teas, acupuncture, massage therapy, magnet therapy, spiritual healing, and meditation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complementary and Alternative Medicine","conceptCode":"C15178","definition":"A group of diverse medical and health care systems, practices, and products that are not presently considered to be part of conventional medicine. Complementary medicine as being used together with conventional medicine, whereas alternative medicine is used in place of conventional medicine. The National Center for Complementary and Alternative Medicine (NCCAM) groups CAM practices into four domains, recognizing there can be some overlap: mind-body medicine; biologically based practices, manipulative and body-based practices, and energy medicine. In addition, NCCAM studies CAM whole medical systems, which cut across all domains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DED3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"LUY","dateModified":"2015-01-30","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 01/30/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-86D1-2758-E053-4EBD850AD480","beginDate":"2004-09-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"Cytogenetic Resistance","valueDescription":"Cytogenetic resistance","ValueMeaning":{"publicId":"2563879","version":"1","preferredName":"Cytogenetic resistance","longName":"2563879","preferredDefinition":"The branch of biology that studies the cellular aspects of heredity, especially the chromosomes. Includes the study of disease states caused by numerical and structural chromosome abnormalities.: A Resistance Process consists of activities of biologic molecules or complexes involved in processes that maintain immunity to, or counteract, defeat, or withstand the effects of, an antagonistic agent.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytogenetics","conceptCode":"C16487","definition":"The branch of biology that studies the cellular aspects of heredity, especially the chromosomes. Includes the study of disease states caused by numerical and structural chromosome abnormalities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Resistance Process","conceptCode":"C41546","definition":"A Resistance Process consists of activities of biologic molecules or complexes involved in processes that maintain immunity to, or counteract, defeat, or withstand the effects of, an antagonistic agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C694-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"REEVESD","dateModified":"2016-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-86DB-2758-E053-4EBD850AD480","beginDate":"2005-06-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"Disease Progression before active treatment","valueDescription":"Disease progression before active treatment","ValueMeaning":{"publicId":"2563881","version":"1","preferredName":"Disease progression before active treatment","longName":"2563881","preferredDefinition":"Disease progression before active treatment","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C696-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-86E5-2758-E053-4EBD850AD480","beginDate":"2005-06-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"Reduction due to toxicity","valueDescription":"Reduction due to toxicity","ValueMeaning":{"publicId":"2573685","version":"1","preferredName":"Reduction due to toxicity","longName":"2573685","preferredDefinition":"Reduction due to toxicity","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-ECE2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-22","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-03-22","modifiedBy":"CAMPBELB","dateModified":"2005-03-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-86EF-2758-E053-4EBD850AD480","beginDate":"2005-03-22","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"Interruption due to hypersensitivity","valueDescription":"Interruption due to hypersensitivity","ValueMeaning":{"publicId":"2573684","version":"1","preferredName":"Interruption due to hypersensitivity","longName":"2573684","preferredDefinition":"Interruption due to hypersensitivity","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-ECE1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-22","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-03-22","modifiedBy":"CAMPBELB","dateModified":"2005-03-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-86F9-2758-E053-4EBD850AD480","beginDate":"2005-03-22","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"Delay per protocol","valueDescription":"Delay per protocol","ValueMeaning":{"publicId":"2573683","version":"1","preferredName":"Delay per protocol","longName":"2573683","preferredDefinition":"Delay per protocol","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-ECE0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-22","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-03-22","modifiedBy":"CAMPBELB","dateModified":"2005-03-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-8703-2758-E053-4EBD850AD480","beginDate":"2005-03-22","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"Lost to follow-up","valueDescription":"Lost to Follow-up","ValueMeaning":{"publicId":"2561825","version":"1","preferredName":"Lost to Follow-up","longName":"2561825v1.00","preferredDefinition":"The loss or lack of continuation of subject participation after a study has officially closed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lost To Follow-Up","conceptCode":"C48227","definition":"The loss or lack of continuation of subject participation after a study has officially closed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-BE8E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-07-10","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-10","modifiedBy":"KUMMEROA","dateModified":"2023-08-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-870D-2758-E053-4EBD850AD480","beginDate":"2005-06-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"No modification","valueDescription":"No modification","ValueMeaning":{"publicId":"2576120","version":"1","preferredName":"No modification","longName":"2576120","preferredDefinition":"No modification","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F665-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-07","modifiedBy":"CAMPBELB","dateModified":"2005-09-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-8717-2758-E053-4EBD850AD480","beginDate":"2005-09-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"Missed Dose","valueDescription":"Missed Dose","ValueMeaning":{"publicId":"3595458","version":"1","preferredName":"Missed Dose","longName":"3595458","preferredDefinition":"A dose of medicine that was not taken at the prescribed dosing interval.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Missed Dose","conceptCode":"C50429","definition":"A dose of medicine that was not taken at the prescribed dosing interval.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CA37EE3F-3820-0617-E040-BB89AD43287E","latestVersionIndicator":"Yes","beginDate":"2012-09-21","endDate":null,"createdBy":"KRYSTKIA","dateCreated":"2012-09-21","modifiedBy":"KUMMEROA","dateModified":"2023-03-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-8721-2758-E053-4EBD850AD480","beginDate":"2012-09-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"Non-protocol delay","valueDescription":"Non-Protocol Delay","ValueMeaning":{"publicId":"3595755","version":"1","preferredName":"Non-Protocol Delay","longName":"3595755","preferredDefinition":"Treatment not specified in a protocol.: Delay; time during which some action is awaited; inactivity resulting in something being put off until a later time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-Protocol","conceptCode":"C25590","definition":"Treatment not specified in a protocol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Delay","conceptCode":"C25476","definition":"Time during which some action is awaited; inactivity resulting in something being put off until a later time; the state of being slower or later.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CA77A603-F5A8-9C37-E040-BB89AD436956","latestVersionIndicator":"Yes","beginDate":"2012-09-24","endDate":null,"createdBy":"KRYSTKIA","dateCreated":"2012-09-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-872B-2758-E053-4EBD850AD480","beginDate":"2012-09-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"Neutropenia","valueDescription":"Neutropenia","ValueMeaning":{"publicId":"4291757","version":"1","preferredName":"Neutropenia","longName":"4291757","preferredDefinition":"A decrease in the number of neutrophils in the peripheral blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neutropenia","conceptCode":"C80520","definition":"A decrease in the number of neutrophils in the peripheral blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ABEA26-63D5-ED7C-E040-BB89AD4312B2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-8735-2758-E053-4EBD850AD480","beginDate":"2015-04-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"Bilirubin elevation","valueDescription":"Bilirubin elevation","ValueMeaning":{"publicId":"4770852","version":"1","preferredName":"Bilirubin elevation","longName":"4770852","preferredDefinition":"A bile pigment that is a degradation product of HEME.: The condition of being elevated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bilirubin","conceptCode":"C305","definition":"A dark orange, yellow pigment that is the product of the breakdown of iron in the blood; it is conjugated in the liver and excreted in the bile.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Elevation","conceptCode":"C25494","definition":"The condition of being elevated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"12C55855-DC25-AD11-E050-BB89AD4346D9","latestVersionIndicator":"Yes","beginDate":"2015-04-02","endDate":null,"createdBy":"WONGW","dateCreated":"2015-04-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-873F-2758-E053-4EBD850AD480","beginDate":"2015-04-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"AST/ALT elevation","valueDescription":"AST/ALT elevation","ValueMeaning":{"publicId":"4770853","version":"1","preferredName":"AST/ALT elevation","longName":"4770853","preferredDefinition":"Activity measured as a test of liver function, 46/47-kDa homodimeric human Aspartate Aminotransferases (Class-I Pyridoxal-Phosphate-Dependent Aminotransferase Family) are pyridoxal phosphate-dependent enzymes involved in amino acid metabolism and in the urea and tricarboxylic acid cycles. (NCI): Activity measured as a test of liver function, human Glutamic-Pyruvate Transaminases (Alanine Aminotransferase Family) are pyridoxal phosphate-dependent enzymes involved in cellular nitrogen metabolism, amino acid metabolism, and liver gluconeogenesis. Glutamic Pyruvic Transaminases mediate conversion of major intermediate metabolites, catalyzing reversible transamination between alanine and alpha-ketoglutarate to form pyruvate and glutamate. (NCI): The condition of being elevated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Aspartate Aminotransferase","conceptCode":"C25202","definition":"A family of pyridoxal phosphate-dependent enzymes involved in amino acid metabolism and in the urea and tricarboxylic acid cycles. Aspartate aminotransferase specifically and reversibly catalyzes the transfer of an amino group from L-aspartate to alpha-ketoglutarate forming oxaloacetate and L-glutamate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Alanine Aminotransferase","conceptCode":"C25293","definition":"A family of pyridoxal phosphate-dependent enzymes involved in cellular nitrogen metabolism, amino acid metabolism, and liver gluconeogenesis. Alanine aminotransferase specifically and reversibly catalyzes the transfer of an amino group from L-alanine to alpha-ketoglutarate forming pyruvate and L-glutamate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Elevation","conceptCode":"C25494","definition":"The condition of being elevated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"12C55855-DC4C-AD11-E050-BB89AD4346D9","latestVersionIndicator":"Yes","beginDate":"2015-04-02","endDate":null,"createdBy":"WONGW","dateCreated":"2015-04-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-8749-2758-E053-4EBD850AD480","beginDate":"2015-04-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"APL Differentiation Syndrome","valueDescription":"APL Differentiation Syndrome","ValueMeaning":{"publicId":"4770854","version":"1","preferredName":"APL Differentiation Syndrome","longName":"4770854","preferredDefinition":"A syndrome observed in patients with acute promyelocytic leukemia treated with all-trans retinoic acid. It is characterized by weight gain, dyspnea, pleural and pericardial effusions, leukocytosis, and renal failure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"APL Differentiation Syndrome","conceptCode":"C78597","definition":"A syndrome observed in patients with acute promyelocytic leukemia treated with all-trans retinoic acid. It is characterized by weight gain, dyspnea, pleural and pericardial effusions, leukocytosis, and renal failure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"12C55855-DC6F-AD11-E050-BB89AD4346D9","latestVersionIndicator":"Yes","beginDate":"2015-04-02","endDate":null,"createdBy":"WONGW","dateCreated":"2015-04-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-8753-2758-E053-4EBD850AD480","beginDate":"2015-04-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"Pseudotumor Cerebri","valueDescription":"Pseudotumor Cerebri","ValueMeaning":{"publicId":"3211399","version":"1","preferredName":"Pseudotumor Cerebri","longName":"3211399","preferredDefinition":"An idiopathic disorder characterized by chronic increase in the intracranial pressure. It occurs predominantly in obese females of childbearing age. It is associated with papilledema.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pseudotumor Cerebri","conceptCode":"C85035","definition":"An idiopathic disorder characterized by chronic increase in the intracranial pressure. It occurs predominantly in obese females of childbearing age. It is associated with papilledema.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-F865-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-875D-2758-E053-4EBD850AD480","beginDate":"2015-04-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"Prolonged QTc","valueDescription":"Prolonged QTc","ValueMeaning":{"publicId":"4770856","version":"1","preferredName":"Prolonged QTc","longName":"4770856","preferredDefinition":"Vo value exists.: The time interval between the start of the Q wave and the end of the T wave in the cardiac cycle as corrected with a non-specified correction formula.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prolonged","conceptCode":"C0439590","definition":"Vo value exists.","evsSource":"UMLS_CUI","primaryIndicator":"No","displayOrder":"1"},{"longName":"Corrected QT Interval","conceptCode":"C100391","definition":"The time interval between the start of the Q wave and the end of the T wave in the cardiac cycle as corrected with a non-specified correction formula.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"12C55855-DCC6-AD11-E050-BB89AD4346D9","latestVersionIndicator":"Yes","beginDate":"2015-04-02","endDate":null,"createdBy":"WONGW","dateCreated":"2015-04-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-8767-2758-E053-4EBD850AD480","beginDate":"2015-04-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"Other Cardiotoxicity","valueDescription":"Other Cardiotoxicity","ValueMeaning":{"publicId":"4770855","version":"1","preferredName":"Other Cardiotoxicity","longName":"4770855","preferredDefinition":"Different than the one(s) previously specified or mentioned.: Toxicity that impairs or damages the heart. This condition is often caused by the administration of a pharmaceutical agent that initiates a poisonous or toxic response in cardiac tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cardiotoxicity","conceptCode":"C27994","definition":"Toxicity that impairs or damages the heart. This condition is often caused by the administration of a pharmaceutical agent that initiates a poisonous or toxic response in cardiac tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"12C55855-DCA0-AD11-E050-BB89AD4346D9","latestVersionIndicator":"Yes","beginDate":"2015-04-02","endDate":null,"createdBy":"WONGW","dateCreated":"2015-04-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C975B0E3-8771-2758-E053-4EBD850AD480","beginDate":"2015-04-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"ONEDATA","dateModified":"2021-08-13","deletedIndicator":"No"},{"value":"Protocol-defined dose escalation","valueDescription":"Protocol-defined dose escalation","ValueMeaning":{"publicId":"8176569","version":"1","preferredName":"Protocol-defined dose escalation","longName":"8176569","preferredDefinition":"Protocol-defined dose escalation","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DD43732B-67DE-761B-E053-4EBD850ABC15","latestVersionIndicator":"Yes","beginDate":"2022-04-22","endDate":null,"createdBy":"RAGUNATU","dateCreated":"2022-04-22","modifiedBy":"ONEDATA","dateModified":"2022-04-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD43732B-67F7-761B-E053-4EBD850ABC15","beginDate":"2022-04-22","endDate":null,"createdBy":"RAGUNATU","dateCreated":"2022-04-22","modifiedBy":"ONEDATA","dateModified":"2022-04-22","deletedIndicator":"No"},{"value":"Washout Period","valueDescription":null,"ValueMeaning":{"publicId":"6353422","version":"1","preferredName":"Washout Period","longName":"6353422","preferredDefinition":"A period of time to allow one agent to clear the body before another agent can be safely introduced.  Washout periods vary depending on the agents involved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Washout Period","conceptCode":"C42872","definition":"A period of time to allow one agent to clear the body before another agent can be safely introduced.  Washout periods vary depending on the agents involved.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"70D0906E-FE95-71BD-E053-F662850A4101","latestVersionIndicator":"Yes","beginDate":"2018-07-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-07-12","modifiedBy":"ONEDATA","dateModified":"2018-07-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"05A33D63-09BB-23CD-E063-731AD00A97BE","beginDate":"2023-09-18","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-09-18","modifiedBy":"MMADDINENI","dateModified":"2023-09-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008560","version":"1","preferredName":"Therapy Doses","preferredDefinition":"quantities of therapy or treatment.","longName":"TX_DOSES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30C55B6-50B5-1219-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2240632","version":"1","preferredName":"Reason","preferredDefinition":"An explanation of the cause of some phenomenon or action.","longName":"C25638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F9FA7953-8391-043D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-30","endDate":null,"createdBy":"PWEST","dateCreated":"2005-06-30","modifiedBy":"ONEDATA","dateModified":"2005-06-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C975B0E3-8657-2758-E053-4EBD850AD480","latestVersionIndicator":"Yes","beginDate":"2021-08-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"MMADDINENI","dateModified":"2023-09-18","changeDescription":"version to match main values to current CDUS values; other values permitted for reduction or change in dose only.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4171051","version":"1","longName":"RTOG-1016","context":"NRG"},{"publicId":"4104934","version":"1","longName":"RTOG-1216","context":"NRG"},{"publicId":"4104935","version":"1","longName":"RTOG-1221","context":"NRG"},{"publicId":"4171052","version":"1","longName":"RTOG-0920","context":"NRG"},{"publicId":"4104937","version":"1","longName":"RTOG-1306","context":"NRG"},{"publicId":"4104933","version":"1","longName":"RTOG-1308","context":"NRG"}]},{"publicId":"7283431","version":"1","longName":"CRF CDEs","context":"AMC","ClassificationSchemeItems":[{"publicId":"10000342","version":"1","longName":"Follow-Up","context":"AMC"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Reason for Treatment Modifica","type":"Preferred Question Text","description":"Reason for Treatment Modification","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Reason for dose modification","url":null,"context":"CTEP"},{"name":"1-COMMENT","type":"COMMENT","description":"This CDE may not be used for Off-Treatment or End of Treatment - only for modification or dose change; for Off-Treatment, see CDE #2186 with CDUS value for reporting","url":null,"context":"CTEP"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"[ATO] dose modification reason:","url":null,"context":"CTEP"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"[ATRA] dose modification reason:","url":null,"context":"CTEP"},{"name":"COG CRF Text 3","type":"Alternate Question Text","description":"Dose modification reason:","url":null,"context":"CTEP"},{"name":"AMC Question Text 2","type":"Alternate Question Text","description":"RT Modification Reason","url":null,"context":"AMC"},{"name":"AMC Question Text","type":"Alternate Question Text","description":"Dose Modification Reason","url":null,"context":"AMC"}],"origin":"NCIC CRF:National Cancer Institute of Canada Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C977A203-68A6-1A93-E053-4EBD850A2750","latestVersionIndicator":"Yes","beginDate":"2021-08-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-08-13","modifiedBy":"CAMPBELB","dateModified":"2021-08-13","changeDescription":"** ISO COMPLIANCE ** Lung Change Management 10/07","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}